On March 14, 2023, Assoc. Prof. Thira Worathanarat, M.D., Faculty of Medicine Chulalongkorn University Post a message via Facebook Thira Woratanarat stating the message…
Yesterday, around the world, there were 45,914 more infections, 278 more deaths, a total of 681,605,045 people, 6,812,238 deaths.
The top 5 most infected are Russia, Taiwan, Romania, South Korea and Japan.
As of yesterday, in the number of new infections, countries from Europe and Asia occupied seven of the top 10 and 16 of the top 20 globally.
The number of new infections per day around the world right now from Asia and Europe combined, representing 82.51 percent of the world, while the number of deaths accounted for 87.76 percent
…updating knowledge of COVID-19
1. The situation of infection in Japan
After eight waves of COVID-19, antibody surveys show that 50% of people in their 20s-40s are infected, while 60% are among teenagers.
2. Molnupiravir and Paxlovid reduce the risk of death in both infected patients hospitalized. Both people who have been vaccinated and not vaccinated.
The latest research from Fai Wan EY and the University of Hong Kong team. The study was conducted among 16,495 infected patients who were hospitalized from February to July 2022.
A 13% and 23% reduction in risk of all-cause mortality among patients receiving Molnupiravir and Paxlovid, respectively.
3. Long COVID in children found about 23%
Zheng YB and colleagues from Peking University, China, conducted a systematic review of research around the world. A meta-analysis was conducted to look at the prevalence rate of Long COVID in children.
It was found that there were 40 studies in total, with a total population of 12,424 people.
The symptoms of chronic disorders that occur are similar to those in adults. occur in every system in the body
It was also found that Among pediatric patients with Long COVID, about 14.89% will still have at least one symptom 12 months after infection.
In addition, children over the age of 10 are at a higher risk of developing long-term COVID-19 symptoms and are at a higher risk of developing multi-organ inflammatory disease (MISC).
…daily life You should protect yourself regularly.
Watch out for risky behavior. sharing of food and crowded places
Try to adjust the environment, where you live, where you work, where you study, where you eat, drink, and travel to have better ventilation than in the past.
wearing a mask correctly It will greatly reduce the risk of both COVID-19 and PM2.5.
refer
1.
2. Fai Wan EY et al. Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19. Annals of Internal Medicine. 14 March 2023.
3. Zheng YB et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. Journal of Infection and Public Health. 7 March 2023.
